Cargando…

Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy

PURPOSE: This qualitative study aimed to identify hematopoietic stem cell transplantation (HSCT) survivors’ (1) work perceptions; (2) barriers to and facilitators of return to work (RTW); and (3) possible solutions to improve RTW. METHOD: Fifteen patients treated with HSCT 1–5 years ago participated...

Descripción completa

Detalles Bibliográficos
Autores principales: Persoon, S., Buffart, L. M., Chinapaw, M. J. M., Nollet, F., Frings-Dresen, M. H., Koning, S., Kersten, M. J., Tamminga, S. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597586/
https://www.ncbi.nlm.nih.gov/pubmed/30591967
http://dx.doi.org/10.1007/s00520-018-4596-0
_version_ 1783430611219775488
author Persoon, S.
Buffart, L. M.
Chinapaw, M. J. M.
Nollet, F.
Frings-Dresen, M. H.
Koning, S.
Kersten, M. J.
Tamminga, S. J.
author_facet Persoon, S.
Buffart, L. M.
Chinapaw, M. J. M.
Nollet, F.
Frings-Dresen, M. H.
Koning, S.
Kersten, M. J.
Tamminga, S. J.
author_sort Persoon, S.
collection PubMed
description PURPOSE: This qualitative study aimed to identify hematopoietic stem cell transplantation (HSCT) survivors’ (1) work perceptions; (2) barriers to and facilitators of return to work (RTW); and (3) possible solutions to improve RTW. METHOD: Fifteen patients treated with HSCT 1–5 years ago participated in face-to-face semi-structured interviews. Interviews were analyzed following the steps of thematic content analyses. RESULTS: RTW was often characterized as a complex and prolonged trajectory, and it was frequently incomplete in working hours, tasks, and/or responsibilities. Work perceptions varied between patients; most valued work as positive, but some also reported a decline in work capacity and/or in importance. Perceived barriers included the duration and side effects of cancer treatment, the presence of comorbidity and poor health before diagnosis, having difficulties commuting and doing household tasks. Perceived facilitators were financial incentives, keeping in touch with the workplace, support of other patients and family, and looking after one’s health. Proposed solutions to improve RTW included discussing RTW at the hospital, enhanced employer support, improved accessibility of rehabilitation programs, and more information about the consequences of being sick-listed. CONCLUSIONS: Many HSCT survivors value work as important and they are motivated to RTW. Insight in work perceptions, RTW barriers, and solutions might help researchers, healthcare professionals, and employers to develop and/or tailor individualized multidisciplinary care to facilitate RTW.
format Online
Article
Text
id pubmed-6597586
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-65975862019-07-18 Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy Persoon, S. Buffart, L. M. Chinapaw, M. J. M. Nollet, F. Frings-Dresen, M. H. Koning, S. Kersten, M. J. Tamminga, S. J. Support Care Cancer Original Article PURPOSE: This qualitative study aimed to identify hematopoietic stem cell transplantation (HSCT) survivors’ (1) work perceptions; (2) barriers to and facilitators of return to work (RTW); and (3) possible solutions to improve RTW. METHOD: Fifteen patients treated with HSCT 1–5 years ago participated in face-to-face semi-structured interviews. Interviews were analyzed following the steps of thematic content analyses. RESULTS: RTW was often characterized as a complex and prolonged trajectory, and it was frequently incomplete in working hours, tasks, and/or responsibilities. Work perceptions varied between patients; most valued work as positive, but some also reported a decline in work capacity and/or in importance. Perceived barriers included the duration and side effects of cancer treatment, the presence of comorbidity and poor health before diagnosis, having difficulties commuting and doing household tasks. Perceived facilitators were financial incentives, keeping in touch with the workplace, support of other patients and family, and looking after one’s health. Proposed solutions to improve RTW included discussing RTW at the hospital, enhanced employer support, improved accessibility of rehabilitation programs, and more information about the consequences of being sick-listed. CONCLUSIONS: Many HSCT survivors value work as important and they are motivated to RTW. Insight in work perceptions, RTW barriers, and solutions might help researchers, healthcare professionals, and employers to develop and/or tailor individualized multidisciplinary care to facilitate RTW. Springer Berlin Heidelberg 2018-12-27 2019 /pmc/articles/PMC6597586/ /pubmed/30591967 http://dx.doi.org/10.1007/s00520-018-4596-0 Text en © The Author(s) 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Persoon, S.
Buffart, L. M.
Chinapaw, M. J. M.
Nollet, F.
Frings-Dresen, M. H.
Koning, S.
Kersten, M. J.
Tamminga, S. J.
Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy
title Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy
title_full Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy
title_fullStr Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy
title_full_unstemmed Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy
title_short Return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy
title_sort return to work experiences of patients treated with stem cell transplantation for a hematologic malignancy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6597586/
https://www.ncbi.nlm.nih.gov/pubmed/30591967
http://dx.doi.org/10.1007/s00520-018-4596-0
work_keys_str_mv AT persoons returntoworkexperiencesofpatientstreatedwithstemcelltransplantationforahematologicmalignancy
AT buffartlm returntoworkexperiencesofpatientstreatedwithstemcelltransplantationforahematologicmalignancy
AT chinapawmjm returntoworkexperiencesofpatientstreatedwithstemcelltransplantationforahematologicmalignancy
AT nolletf returntoworkexperiencesofpatientstreatedwithstemcelltransplantationforahematologicmalignancy
AT fringsdresenmh returntoworkexperiencesofpatientstreatedwithstemcelltransplantationforahematologicmalignancy
AT konings returntoworkexperiencesofpatientstreatedwithstemcelltransplantationforahematologicmalignancy
AT kerstenmj returntoworkexperiencesofpatientstreatedwithstemcelltransplantationforahematologicmalignancy
AT tammingasj returntoworkexperiencesofpatientstreatedwithstemcelltransplantationforahematologicmalignancy